Skip to main content
Midas Edge

ALUMIS INC.

For the period ended Jun 30, 2026. Filed Aug 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 13, 2026

ALMS$6.40-2.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders’ Equity

​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Accumulated · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · ​ · ​ · ​ · Additional · Other · ​ · ​ · Total
​ · ​ · Common Stock · Paid-In · Comprehensive · Accumulated · Stockholders’
(in thousands, except share amounts) · ​ ​ · Shares · ​ ​ · Amount · ​ · Capital · ​ ​ · Income (Loss) · ​ ​ · Deficit · ​ ​ · Equity
Balance at December 31, 2025104,706,773​$10​$1,202,975​$188​$(901,876)​$301,297
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs of $21,26020,297,500​2​323,797​—​—​323,799
Issuance of common stock upon exercise of stock options2,177,964​—​23,265​—​—​23,265
Issuance of common stock upon vesting of restricted stock units47,509​—​—​—​—​—
Vesting of early exercised stock options—​—​29​—​—​29
Stock-based compensation expense—​—​12,339​—​—​12,339
Other comprehensive income (loss), net—​—​—​(655)​—​(655)
Net income (loss)—​—​—​—​(93,053)​(93,053)
Balance at March 31, 2026127,229,746​$12​$1,562,405​$(467)​$(994,929)​$567,021
​​​​​​​​​​​​​​​​​​
Issuance of common stock upon exercise of stock options1,001,393​​—​​11,708​​—​​—​​11,708
Issuance of common stock upon vesting of restricted stock units​21,156​​—​​—​​—​​—​​—
Issuance of common stock under the 2024 Employee Stock Purchase Plan​253,150​​—​​1,570​​—​​—​​1,570
Vesting of early exercised stock options—​​—​​23​​—​​—​​23
Stock-based compensation expense—​​—​​14,273​​—​​—​​14,273
Other comprehensive income (loss), net​—​​—​​—​​(216)​​—​​(216)
Net income (loss)—​​—​​—​​—​​(142,221)​​(142,221)
Balance at June 30, 2026128,505,445​$12​$1,589,979​$(683)​$(1,137,150)​$452,158
​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Accumulated · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · ​ · ​ · ​ · Additional · Other · ​ · ​ · Total
​ · ​ · Common Stock · Paid-In · Comprehensive · Accumulated · Stockholders’
(in thousands, except share amounts) · ​ ​ · Shares · ​ ​ · Amount · ​ · Capital · ​ ​ · Income (Loss) · ​ ​ · Deficit · ​ ​ · Equity
Balance at December 31, 202454,407,327​$5​$918,610​$40​$(658,551)​$260,104
Vesting of early exercised stock options—​—​224​—​—​224
Vesting of restricted shares of common stock—​—​2​—​—​2
Stock-based compensation expense​—​​—​​6,995​​—​​—​​6,995
Other comprehensive income (loss), net—​—​—​(48)​—​(48)
Net income (loss)—​—​—​—​(98,963)​(98,963)
Balance at March 31, 202554,407,327​$5​$925,831​$(8)​$(757,514)​$168,314
​​​​​​​​​​​​​​​​​​
Issuance of common stock and equity awards in connection with the ACELYRIN Merger​48,653,549​​5​​238,072​​—​​—​​238,077
Issuance of common stock upon vesting of restricted stock units​798,751​​—​​—​​—​​—​​—
Issuance of common stock under the 2024 Employee Stock Purchase Plan184,633​—​766​—​—​766
Vesting of early exercised stock options—​—​184​—​—​184
Repurchase of common stock issued upon early exercise of stock options​(1,783)​​—​​—​​—​​—​​—
Stock-based compensation expense​—​​—​​18,635​​—​​—​​18,635
Other comprehensive income (loss), net​—​​—​​—​​30​​—​​30
Net income (loss)—​—​—​—​59,321​59,321
Balance at June 30, 2025104,042,477​$10​$1,183,488​$22​$(698,193)​$485,327
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.